SCHEMBL312410

SCHEMBL312410

CCOC(=O)Cc1cc(O)ccc1-c1cc(=O)c2cc(O)ccc2o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.52
HPGD P15428 5/20 0.52
CYP2C19 P33261 4/20 0.52
ALDH1A1 P00352 3/20 0.52
TSHR P16473 2/20 0.52
CSNK2A2 P19784 5/20 0.51
CSNK2B P67870 5/20 0.51
CSNK2A1 P68400 5/20 0.51
MAPT P10636 5/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
TP53 P04637 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
LMNA P02545 1/20 0.49
THRB P10828 1/20 0.49
ALOX15 P16050 1/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10215485 0.91 HPGD (0.59) CYP3A4HPGDCYP2C19ALDH1A1TSHR
SCHEMBL312252 0.91 AKR1B1 (0.46) CYP3A4HPGDCYP2C19ALDH1A1TSHR
SCHEMBL312740 0.91 AKR1B1 (0.57) CYP3A4HPGDCYP2C19ALDH1A1TP53
SCHEMBL311334 0.86 EGFR (0.46) HPGDALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL311402 0.84 ATM (0.53) CYP3A4HPGDCYP2C19ALDH1A1MAPT
SCHEMBL312442 0.84 BACE1 (0.62) CYP3A4HPGDCYP2C19ALDH1A1TSHR
SCHEMBL311828 0.83 CYP2D6 (0.46) CYP3A4HPGDCYP2C19ALDH1A1TSHR
SCHEMBL311962 0.80 EGFR (0.47) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL312219 0.80 CYP3A4 (0.58) CYP3A4HPGDCYP2C19ALDH1A1TSHR
SCHEMBL311791 0.79 HPGD (0.51) CYP3A4HPGDCYP2C19ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed